Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 9, 2014, Pages 4019-4023

  Sun, Xiao Jin ^a   Zhang, Pei ^a   Li, Hai Hui ^a   Jiang, Zhi Wen ^a   Jiang, Chen Chen ^a,b   Liu, Hao ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cisplatin; Invasion; Metastasis; Metformin; NPC

Indexed keywords

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; CADHERIN; CISPLATIN; GELATINASE B; METFORMIN;

BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; HUMAN; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; DOWN-REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; MATRIX METALLOPROTEINASE 9; METFORMIN; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; UP-REGULATION;

EID: 84902660009     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.9.4019     Document Type: Article

References (19)

1. Anisimov VN, Berstein LM, Egormin PA et al (2005). Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol, 40, 685-93.
2. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF et al (2010). Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther, 9, 1092-9.
3. Ben Sahra I, Laurent K, Loubat A, et al (2008). The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene, 27, 3576-86.
4. Chen J, Dassarath M, Yin Z et al (2011). Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management. Radiat Oncol, 6, 128.
5. Decensi A, Puntoni M, Goodwin P et al. (2010). Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res, 3, 1451-61.
6. Fedorcsak P, Dale PO, Storeng R et al. (2003). The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial. Gynecol Endocrinol, 17, 207-14.
7. Fan FT, Shen CS, Tao L et al (2013). PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation. Asian Pac J Cancer Prev, 14, 5533-7.
8. Huang CD, Tang MZ. (2009). Progress of treating nasopharyngeal carcinoma by Chinese pharmacy and radiotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi, 33, 1575-8.
9. Hsieh MC, Lee TC, Cheng SM et al (2012). The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res, 2012, 413782.
10. Hwang YP, Jeong HG (2010). Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1. Br J Pharmacol, 160, 1195-211.
11. Jiralerspong S, Palla SL, Giordano SH et al (2009). Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol, 2, 3297-302.
12. Kato K, Gong J, Iwama H et al (2012). The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther, 11, 549-60.
13. Rattan R, Giri S, Hartmann LC et al (2011). Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Mech, 15, 166-78.
14. Rattan R, Graham RP, Maguire JL et al (2011). Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia, 13, 483-91.
15. Tan BK, Adya R et al (2011). Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. J Clin Endocrinol Metab, 96, 808-16.
16. Witters LA (2001). The blooming of the French lilac. J Clin Invest, 108, 1105-7.
17. Wurth R, Pattarozzi A, Gatti M et al (2013). Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. Cell Cycle, 12, 145-56.
18. Wu B , Li S, Sheng L et al. Metformin inhibits the development and metastasis of ovarian cancer. Oncol Rep, 28, 903-8.
19. Zakikhani M, Dowling R, Chen J et al (2006). Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res, 66, 10269-73.